{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,8]],"date-time":"2026-03-08T10:20:44Z","timestamp":1772965244767,"version":"3.50.1"},"reference-count":37,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,2,1]],"date-time":"2023-02-01T00:00:00Z","timestamp":1675209600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,2,1]],"date-time":"2023-02-01T00:00:00Z","timestamp":1675209600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,2,1]],"date-time":"2023-02-01T00:00:00Z","timestamp":1675209600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,2,1]],"date-time":"2023-02-01T00:00:00Z","timestamp":1675209600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,2,1]],"date-time":"2023-02-01T00:00:00Z","timestamp":1675209600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,2,1]],"date-time":"2023-02-01T00:00:00Z","timestamp":1675209600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,2,1]],"date-time":"2023-02-01T00:00:00Z","timestamp":1675209600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100004735","name":"Natural Science Foundation of\u00a0Hunan Province","doi-asserted-by":"publisher","award":["2022JJ30911"],"award-info":[{"award-number":["2022JJ30911"]}],"id":[{"id":"10.13039\/501100004735","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biochemical and Biophysical Research Communications"],"published-print":{"date-parts":[[2023,2]]},"DOI":"10.1016\/j.bbrc.2022.12.055","type":"journal-article","created":{"date-parts":[[2022,12,29]],"date-time":"2022-12-29T11:05:02Z","timestamp":1672311902000},"page":"96-102","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"special_numbering":"C","title":["Preliminary mechanism of inhibitor of SGLT2 in fatty liver cold ischemia injury"],"prefix":"10.1016","volume":"646","author":[{"given":"Hanwen","family":"Yang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qiang","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pengpeng","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ke","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hao","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Huan","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mingxin","family":"Cai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yingzi","family":"Ming","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yujun","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.bbrc.2022.12.055_bib1","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/j.ijsu.2020.05.024","article-title":"Expanding the donor pool for liver transplantation with marginal donors","volume":"82s","author":"Goldaracena","year":"2020","journal-title":"Int. J. Surg."},{"key":"10.1016\/j.bbrc.2022.12.055_bib2","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1053\/jlts.2002.31747","article-title":"Current practice regarding the use of fatty livers: a trans-Atlantic survey","volume":"8","author":"Imber","year":"2002","journal-title":"Liver Transplant."},{"key":"10.1016\/j.bbrc.2022.12.055_bib3","doi-asserted-by":"crossref","first-page":"429","DOI":"10.3389\/fphys.2019.00429","article-title":"Systematic evaluation of the safety threshold for allograft macrovesicular steatosis in cadaveric liver transplantation","volume":"10","author":"Liu","year":"2019","journal-title":"Front. Physiol."},{"key":"10.1016\/j.bbrc.2022.12.055_bib4","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1006\/bbrc.1996.1790","article-title":"Liver ischemic preconditioning is mediated by the inhibitory action of nitric oxide on endothelin","volume":"229","author":"Peralta","year":"1996","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.bbrc.2022.12.055_bib5","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1002\/lt.500040110","article-title":"In\u00a0vivo demonstration of impaired microcirculation in steatotic human liver grafts","volume":"4","author":"Seifalian","year":"1998","journal-title":"Liver Transplant. Surg."},{"key":"10.1016\/j.bbrc.2022.12.055_bib6","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1016\/S0041-1345(96)00158-3","article-title":"Why is fatty liver unsuitable for transplantation? Deterioration of mitochondrial ATP synthesis and sinusoidal structure during cold preservation of a liver with steatosis","volume":"29","author":"Fukumori","year":"1997","journal-title":"Transplant. Proc."},{"key":"10.1016\/j.bbrc.2022.12.055_bib7","doi-asserted-by":"crossref","first-page":"684","DOI":"10.1002\/ar.20715","article-title":"Hepatic microcirculation in fatty liver disease","volume":"291","author":"Farrell","year":"2008","journal-title":"Anat. Rec. (Hoboken)"},{"key":"10.1016\/j.bbrc.2022.12.055_bib8","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1016\/j.bbalip.2009.10.007","article-title":"Fatty liver and lipotoxicity","volume":"1801","author":"Trauner","year":"2010","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.bbrc.2022.12.055_bib9","first-page":"187","article-title":"Knockdown of aquaporin-8 induces mitochondrial dysfunction in 3T3-L1 cells","volume":"4","author":"Ikaga","year":"2015","journal-title":"Biochem. Biophys. Rep."},{"key":"10.1016\/j.bbrc.2022.12.055_bib10","doi-asserted-by":"crossref","first-page":"17497","DOI":"10.1016\/S0021-9258(18)45408-7","article-title":"Purification and partial characterization of the Mr 30,000 integral membrane protein associated with the erythrocyte Rh(D) antigen","volume":"262","author":"Agre","year":"1987","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.bbrc.2022.12.055_bib11","doi-asserted-by":"crossref","first-page":"2977","DOI":"10.1016\/j.bbamcr.2016.09.012","article-title":"Activation of apoptosis signalling pathways by reactive oxygen species","volume":"1863","author":"Redza-Dutordoir","year":"2016","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.bbrc.2022.12.055_bib12","doi-asserted-by":"crossref","first-page":"1373","DOI":"10.1097\/ALN.0b013e31828a7039","article-title":"Atorvastatin-induced cardioprotection of human myocardium is mediated by the inhibition of mitochondrial permeability transition pore opening via tumor necrosis factor-\u03b1 and Janus kinase\/signal transducers and activators of transcription pathway","volume":"118","author":"Lemoine","year":"2013","journal-title":"Anesthesiology"},{"key":"10.1016\/j.bbrc.2022.12.055_bib13","doi-asserted-by":"crossref","first-page":"1282","DOI":"10.1111\/j.1432-2277.2012.01555.x","article-title":"Leptin attenuates ischemia-reperfusion injury in the rat liver","volume":"25","author":"Carbone","year":"2012","journal-title":"Transpl. Int."},{"key":"10.1016\/j.bbrc.2022.12.055_bib14","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1152\/physrev.00017.2013","article-title":"Targeting aldehyde dehydrogenase 2: new therapeutic opportunities","volume":"94","author":"Chen","year":"2014","journal-title":"Physiol. Rev."},{"key":"10.1016\/j.bbrc.2022.12.055_bib15","doi-asserted-by":"crossref","DOI":"10.3390\/ijms19092479","article-title":"Aldehyde dehydrogenase 2 (ALDH2) in rat fatty liver cold ischemia injury","volume":"19","author":"Panisello-Rosell\u00f3","year":"2018","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.bbrc.2022.12.055_bib16","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1152\/physrev.1960.40.4.789","article-title":"Intestinal absorption of sugars","volume":"40","author":"Crane","year":"1960","journal-title":"Physiol. Rev."},{"key":"10.1016\/j.bbrc.2022.12.055_bib17","doi-asserted-by":"crossref","first-page":"2117","DOI":"10.1056\/NEJMoa1504720","article-title":"Empagliflozin, cardiovascular outcomes, and mortality in type 2 diabetes","volume":"373","author":"Zinman","year":"2015","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.bbrc.2022.12.055_bib18","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1093\/cvr\/cvaa123","article-title":"Empagliflozin improves endothelial and cardiomyocyte function in human heart failure with preserved ejection fraction via reduced pro-inflammatory-oxidative pathways and protein kinase G\u03b1 oxidation","volume":"117","author":"Kolijn","year":"2021","journal-title":"Cardiovasc. Res."},{"key":"10.1016\/j.bbrc.2022.12.055_bib19","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1186\/s12933-019-0816-2","article-title":"SGLT2 inhibition with empagliflozin attenuates myocardial oxidative stress and fibrosis in diabetic mice heart","volume":"18","author":"Li","year":"2019","journal-title":"Cardiovasc. Diabetol."},{"key":"10.1016\/j.bbrc.2022.12.055_bib20","doi-asserted-by":"crossref","DOI":"10.3390\/ijms22020818","article-title":"Empagliflozin attenuates non-alcoholic fatty liver disease (NAFLD) in high fat diet fed ApoE((-\/-)) mice by activating autophagy and reducing ER stress and apoptosis","volume":"22","author":"Nasiri-Ansari","year":"2021","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.bbrc.2022.12.055_bib21","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.transproceed.2012.02.031","article-title":"Preservation solutions for liver transplantation in adults: celsior versus custodiol: a systematic review and meta-analysis with an indirect comparison of randomized trials","volume":"45","author":"Lema Zuluaga","year":"2013","journal-title":"Transplant. Proc."},{"key":"10.1016\/j.bbrc.2022.12.055_bib22","doi-asserted-by":"crossref","first-page":"386","DOI":"10.21037\/hbsn.2018.06.08","article-title":"Extended criteria donors in liver transplantation-from marginality to mainstream","volume":"7","author":"Nair","year":"2018","journal-title":"Hepatobiliary Surg. Nutr."},{"key":"10.1016\/j.bbrc.2022.12.055_bib23","doi-asserted-by":"crossref","DOI":"10.1155\/2013\/192029","article-title":"The impact of hepatic steatosis on hepatic ischemia-reperfusion injury in experimental studies: a systematic review","author":"Chu","year":"2013","journal-title":"BioMed Res. Int."},{"key":"10.1016\/j.bbrc.2022.12.055_bib24","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1111\/j.1432-2277.2003.tb00337.x","article-title":"Marginal grafts: finding the correct treatment for fatty livers","volume":"16","author":"Salizzoni","year":"2003","journal-title":"Transpl. Int."},{"key":"10.1016\/j.bbrc.2022.12.055_bib25","doi-asserted-by":"crossref","DOI":"10.3390\/ijms19010109","article-title":"Liver graft susceptibility during static cold storage and dynamic machine perfusion: DCD versus fatty livers","volume":"19","author":"Ferrigno","year":"2017","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.bbrc.2022.12.055_bib26","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1111\/j.1463-1326.2008.00982.x","article-title":"Sodium-glucose co-transporter-2 inhibitors: an emerging new class of oral antidiabetic drug","volume":"11","author":"Idris","year":"2009","journal-title":"Diabetes Obes. Metabol."},{"key":"10.1016\/j.bbrc.2022.12.055_bib27","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1007\/s00395-022-00934-7","article-title":"Cardioprotection by selective SGLT-2 inhibitors in a non-diabetic mouse model of myocardial ischemia\/reperfusion injury: a class or a drug effect?","volume":"117","author":"Nikolaou","year":"2022","journal-title":"Basic Res. Cardiol."},{"key":"10.1016\/j.bbrc.2022.12.055_bib28","doi-asserted-by":"crossref","DOI":"10.1155\/2022\/1197061","article-title":"Empagliflozin enhances autophagy, mitochondrial biogenesis, and antioxidant defense and ameliorates renal ischemia\/reperfusion in nondiabetic rats","author":"Ala","year":"2022","journal-title":"Oxid. Med. Cell. Longev."},{"key":"10.1016\/j.bbrc.2022.12.055_bib29","doi-asserted-by":"crossref","first-page":"12929","DOI":"10.1073\/pnas.2134694100","article-title":"Cardiomyocyte-restricted knockout of STAT3 results in higher sensitivity to inflammation, cardiac fibrosis, and heart failure with advanced age","volume":"100","author":"Jacoby","year":"2003","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.bbrc.2022.12.055_bib30","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1080\/08977190500178745","article-title":"Opposing actions of STAT-1 and STAT-3","volume":"23","author":"Stephanou","year":"2005","journal-title":"Growth Factors"},{"key":"10.1016\/j.bbrc.2022.12.055_bib31","doi-asserted-by":"crossref","first-page":"1077","DOI":"10.3389\/fphys.2017.01077","article-title":"Empagliflozin limits myocardial infarction in\u00a0vivo and cell death in\u00a0vitro: role of STAT3, mitochondria, and redox aspects","volume":"8","author":"Andreadou","year":"2017","journal-title":"Front. Physiol."},{"key":"10.1016\/j.bbrc.2022.12.055_bib32","doi-asserted-by":"crossref","first-page":"2984","DOI":"10.3748\/wjg.v24.i27.2984","article-title":"Role of aldehyde dehydrogenase 2 in ischemia reperfusion injury: an update","volume":"24","author":"Panisello-Rosell\u00f3","year":"2018","journal-title":"World J. Gastroenterol."},{"key":"10.1016\/j.bbrc.2022.12.055_bib33","doi-asserted-by":"crossref","first-page":"251","DOI":"10.3109\/10715762.2013.864761","article-title":"Regulation and therapeutic strategies of 4-hydroxy-2-nonenal metabolism in heart disease","volume":"48","author":"Mali","year":"2014","journal-title":"Free Radic. Res."},{"key":"10.1016\/j.bbrc.2022.12.055_bib34","doi-asserted-by":"crossref","first-page":"15539","DOI":"10.1074\/jbc.R800001200","article-title":"Routes to 4-hydroxynonenal: fundamental issues in the mechanisms of lipid peroxidation","volume":"283","author":"Schneider","year":"2008","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.bbrc.2022.12.055_bib35","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.cellsig.2015.11.006","article-title":"Impaired ALDH2 activity decreases the mitochondrial respiration in H9C2 cardiomyocytes","volume":"28","author":"Mali","year":"2016","journal-title":"Cell. Signal."},{"key":"10.1016\/j.bbrc.2022.12.055_bib36","doi-asserted-by":"crossref","first-page":"1025","DOI":"10.1093\/eurheartj\/ehq253","article-title":"Aldehyde dehydrogenase 2 (ALDH2) rescues myocardial ischaemia\/reperfusion injury: role of autophagy paradox and toxic aldehyde","volume":"32","author":"Ma","year":"2011","journal-title":"Eur. Heart J."},{"key":"10.1016\/j.bbrc.2022.12.055_bib37","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1016\/j.redox.2017.06.009","article-title":"The SGLT2 inhibitor empagliflozin improves the primary diabetic complications in ZDF rats","volume":"13","author":"Steven","year":"2017","journal-title":"Redox Biol."}],"container-title":["Biochemical and Biophysical Research Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006291X2201720X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006291X2201720X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,13]],"date-time":"2025-09-13T12:27:19Z","timestamp":1757766439000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0006291X2201720X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,2]]},"references-count":37,"alternative-id":["S0006291X2201720X"],"URL":"https:\/\/doi.org\/10.1016\/j.bbrc.2022.12.055","relation":{},"ISSN":["0006-291X"],"issn-type":[{"value":"0006-291X","type":"print"}],"subject":[],"published":{"date-parts":[[2023,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Preliminary mechanism of inhibitor of SGLT2 in fatty liver cold ischemia injury","name":"articletitle","label":"Article Title"},{"value":"Biochemical and Biophysical Research Communications","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bbrc.2022.12.055","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}